16.01.2017
- Canadian-headquartered, US-managed drugmaker Valeant said it will sell around $2 billion worth of assets as it sets about paring down its staggering debt burden of around $30...
11.01.2017
- On the rebound from its failed drive to acquire Salix Pharmaceuticals from Canadian drugmaker Valeant in November 2016 – Valeant decided to keep the company – Japanese...
03.01.2017
- An experimental Ebola vaccine initially developed by the Public Health Agency of Canada and the US Army and eventually licensed to Merck, Sharp and Dohme, the international arm of...
05.12.2016
- German drugmaker Boehringer Ingelheim and China Southeast University Institute of Life Sciences have started a joint research project to develop new treatment approaches for...
23.11.2016
- Two former private investigators, the British-Chinese husband and wife team of Peter Humphrey and Yu Yingzeng, have filed suit against GlaxoSmithKline (GSK) in a US district court...
03.11.2016
- Valeant Pharmaceuticals is in advanced discussions with Japan’s Takeda to sell its Salix subsidiary for $10 billion, according to the US business newspaper Wall Street Journal. The...
27.09.2016
- Drugmakers need to learn empathy and not try to defend price hikes that make drugs inaccessible, Andrew Witty, departing CEO of Britain’s largest pharmaceutical producer GSK, told...
29.08.2016
- An extremely bitter proxy battle – rare for Germany – that has rocked generic drugmaker Stada for months culminated in the replacement of supervisory board chairman, Martin Abend...
